gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · NEOGHealthcareDiagnostics

Neogen Corp (NEOG)

$12.46+2.98%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$12.46▲ 106.29% in range
Nov 4, 2025Low $5.41 · High $13.98Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Neogen closed at $12.46 on Nov 4, up 2.98%, 10.9% below its 52-week closing high. Volume of 4.5M shares was 1.27× its 20-day average (above normal).

Split-adjusted performance: +4.2% over one month, +35.7% over six months, +98.1% over one year.

In the quarter ended Aug 31, 2026, revenue was $222.80M, up 6.5% from a year earlier, with a net margin of -5.3%.

Short interest was 11.9M shares at the Oct 15 settlement (5.5% of float, 2.5 days to cover).

Market cap$2.72B218.3M shares
Revenue · quarter$222.8M+6.5% YoY
Diluted EPS$-0.05−129.4% YoY
P/E · TTM—P/S 3.1×
Net margin-5.3%Gross 47.4%
Dividend yieldNone
52-week range5.41 – 13.98−10.9% from high
Volume4.5M1.27× 20-day avg
Volatility · 60d42.2%Annualised
Short % of float5.5%2.5 days to cover
Net cash-$605.6MCash $172.0M
Next earnings—Not scheduled
Split-adjusted performance
1W +2.8%1M +4.2%3M +10.3%6M +35.7%YTD +78.3%1Y +98.1%3Y −17.3%5Y −69.7%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Diagnostics

Percentile among 15 companies (100 = best)

6-month momentum79
Revenue growth75
Net margin75
Value (low P/E)—
Size86

Industry medians: 6-month return +17.4%, revenue growth −2.0%, net margin −26.0%, P/E 46.6×.

Short interest

Details →
Shares short11.9M+0.7% vs prior
Days to cover2.5Settled Oct 15
% of float5.5%
Short vol. 10d44.2%of daily volume

Closest peers by size in Diagnostics

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
NEOGNeogen$12.46+2.98%+35.7%+6.5%−5.3%—$2.72B
CLDXCelldex Therapeutics$29.93+0.74%−13.0%−97.0%−334104.5%—$2.35BCompare
NTLAIntellia Therapeutics$12.31+3.79%−11.1%−46.2%−1392.3%—$1.72BCompare
LNTHLantheus Holdings$101.14+0.34%+17.4%+2.7%19.3%24.0$6.60BCompare
QDELQuidelOrtho$14.35+1.85%+30.9%+2.8%−14.7%—$984.1MCompare
ACHVAchieve Life Sciences$6.98+3.71%+45.4%———$719.7MCompare
MYGNMyriad Genetics$6.02−0.33%+46.5%−10.5%−22.7%—$575.8MCompare
TKNOAlpha Teknova$7.37+0.41%+102.5%+18.5%−26.0%—$454.7MCompare
IDXXIdexx Laboratories$698.55+3.94%+20.6%+9.9%26.1%46.6$55.03BCompare

News about Neogen

All news →
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation - NEOGGlobeNewswire Inc. · 1d ago▼ NegativeNEOG vs. WFCF: Which Food Safety Stock Has Better Prospects?Zacks Investment Research · Oct 20, 2026▲ PositiveZacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve CannabisZacks Investment Research · Oct 12, 2026▲ PositiveCompared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key MetricsZacks Investment Research · Oct 6, 2026▲ PositiveNeogen (NEOG) Q1 Earnings and Revenues Beat EstimatesZacks Investment Research · Oct 6, 2026▲ Positive

Quick answers

What does Neogen do?
Neogen Corp is develop, manufacture and market a diverse line of products and services dedicated to food and animal safety. Its Food Safety segment consists mainly of diagnostic test kits and complementary products (e.g., culture media) sold to food and animal feed producers and processors to preserve the safety and quality of food to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products.
What is NEOG's market cap?
$2.72B, based on the Nov 4 close of $12.46.
Does Neogen pay a dividend?
No regular cash dividend has been paid in the last year.
How much of NEOG is sold short?
11.9M shares, 5.5% of float, as of Oct 15, 2026.
What sector is NEOG in?
Healthcare, in the Diagnostics industry.

About Neogen

Neogen Corp is develop, manufacture and market a diverse line of products and services dedicated to food and animal safety. Its Food Safety segment consists mainly of diagnostic test kits and complementary products (e.g., culture media) sold to food and animal feed producers and processors to preserve the safety and quality of food to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. These products also ensure the general hygiene of the food manufacturing environment. It also have products to determine food quality and nutritional components. Its segments are Food, Animal safety. Majority of revenue comes from Food Safety. It has presence in United states, and International market.

HQ: Lansing, MI1,257 employeesListed Aug 23, 1989neogen.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology